The first target for Co-D is angiosarcoma, a rare and lethal cancer that arises from blood vessels.
News
Stem cell ‘heart patch’ moves closer to clinic
The promise of stem cells to treat cardiovascular disease may soon be a step closer to overcoming the last big hurdle before trials in human patients.
UW–Madison statement on the USDA investigation process
Investigators from the U.S. Department of Agriculture (USDA), one of two federal agencies responsible for enforcement of the federal laws that regulate animal research, are reviewing the procedures and documentation for care of animals in research at the University of Wisconsin–Madison. USDA veterinary medical officers visit UW–Madison and other university campuses several times a year for inspections of animal facilities and policies. Inspections at UW–Madison are often undertaken at the behest of animal rights organizations whose complaints to USDA are drawn from information UW–Madison veterinarians themselves report to the National Institutes of Health’s Office of Laboratory Animal Welfare. UW–Madison’s researchers, veterinarians and staff take their work and the welfare of research animals in their care very seriously, and are working with USDA officials to supply any information they need.
Study finds a key to nerve regeneration
Researchers have found a switch that redirects helper cells in the peripheral nervous system into “repair” mode. A new study suggests tactics that might assist recovery after physical injury.
Nadine Connor named to interim post for research policy and compliance
Connor will oversee many facets of research policy on campus, including human subjects and animal research.
UW-Madison spinoff gets FDA OK for bacteria-killing wound dressing
Microlyte, patented by Imbed Biosciences, will compete in the $2 billion market sector of “advanced wound dressings,” which are used to treat ulcers, burns, bedsores and other difficult wounds.
Botulinum toxin may travel further than expected in nerve cells
Two specific toxins — including the popular drug Botox — have multiple uses for treating many neuromuscular conditions, including frown lines, disabling muscle spasms and migraine headaches.
Botulinum toxin may travel further than expected in nerve cells
Two specific toxins — including the popular drug Botox — have multiple uses for treating many neuromuscular conditions, including frown lines, disabling muscle spasms and migraine headaches.
UW-Madison a leader in Zika research
It’s no accident that researchers at the University of Wisconsin–Madison have taken a lead role addressing the Zika virus epidemic gripping the Americas. Many of them were already at work fighting viruses and mosquito-borne diseases in Central and South America.
Macular degeneration insight identifies promising drugs to prevent vision loss
In tests on mice, drugs that are already on the market prevented damage to the cells that sustain the light-sensitive cells in the eyes.